How much visceral fat is too much?

TOFI describes individuals with normal BMI but excess visceral fat. Research estimates 10-15% of normal-weight adults fall into this category. A normal BMI combined with a waist circumference above WHO thresholds (94 cm for men, 80 cm for women) is a key indicator.

Yes. A meta-analysis by Vissers et al. (2013) found aerobic exercise reduced visceral fat by an average of 6.1% over 12 weeks, even without weight changes. Visceral fat responds more readily to exercise than subcutaneous fat due to higher density of beta-adrenergic receptors.

Consumer scales vary significantly. Clinical-grade devices (InBody 770) correlate reasonably with DEXA (r = 0.80-0.90). Consumer-grade bathroom scales have errors of 20-30% in some studies. Home scales are best used for trend tracking rather than absolute measurement.

WHO thresholds: for men, below 94 cm (37 inches) is low risk; for women, below 80 cm (31.5 inches). These are population-level thresholds. For South Asian and East Asian populations, lower thresholds (men: 90 cm) may be more appropriate. Discuss with your doctor if you are near or above these values.

CT and MRI scans directly image fat deposits around organs. DEXA scans provide a reliable estimate with lower radiation exposure and cost ($100-300 for DEXA, $500+ for CT/MRI). Waist circumference is the most practical screening tool validated by WHO because it is free and correlates strongly with DEXA-measured visceral fat in population studies. Consumer bioelectrical impedance scales provide estimates for trend tracking but are less accurate than clinical-grade devices.

Some visceral fat is essential. It cushions and protects organs and plays a role in immune function. However, clinical deficiency of visceral fat is extremely rare and almost exclusively seen in severe eating disorders, cachexia from advanced illness, or certain genetic lipodystrophy syndromes. For the vast majority of people, the health concern is excess visceral fat, not insufficient visceral fat. Athletes and highly active individuals commonly have very low visceral fat levels without adverse effects.

For predicting metabolic risk, yes. Multiple systematic reviews have found that waist circumference is a stronger predictor of cardiovascular disease, type 2 diabetes, and all-cause mortality than BMI (Janssen et al., 2004, Obesity Reviews). BMI cannot distinguish between muscle, bone, and fat, whereas waist circumference directly captures abdominal fat distribution. A person with a normal BMI but elevated waist circumference is at higher risk than their BMI alone suggests. The WHO now recommends measuring waist circumference in addition to BMI for clinical risk assessment.

Men typically accumulate visceral fat at a younger age and in greater quantities than pre-menopausal women at equivalent BMI levels. Women store proportionally more subcutaneous fat (on the hips and thighs) than visceral fat up until menopause, when oestrogen loss causes a shift toward abdominal fat storage. This is why women's cardiovascular risk increases sharply after menopause: visceral fat accumulation accelerates. Post-menopausal women have visceral fat levels more comparable to men of similar age. This biological difference means that the same waist circumference carries different risk implications at different life stages for women.